ScoutQuest29 Sep 2026
Kronox Lab Sciences544187Merger deal announced

Control changes hands: 64.26% stake transferred to Indo Borax, board and KMP reconstituted

Ownership change completed.

9.95%Sellers' residual holding %
Sellers' residual holding %: 9.95%.
Equity shares transferred
2,38,44,000 equity shares
Ownership stake transferred
64.26% of paid-up capital
Acquiring company
Indo Borax & Chemicals Ltd
Transaction date
September 29, 2026
Former promoters' remaining stake
36,90,000 shares (9.95%)

What happened

The sale under the share purchase agreement dated August 20, 2026 has been completed. The Sellers — Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani and Jogindersingh Gianchand Jaswal — transferred 2,38,44,000 equity shares, being 64.26% of the total paid-up equity share capital, to Indo Borax & Chemicals Limited on September 29, 2026. Zenrock Chemicals Private Limited was also a party to the SPA.

After the transaction the Sellers collectively hold 36,90,000 equity shares, or 9.95% of the voting share capital, and they, along with other promoter group members, have ceased to be promoters/promoter group of the company.

Board changes approved

These appointments are stated to be pursuant to the board reorganisation being undertaken in accordance with the SPA.

Exits on the same day

Committees reconstituted

The Audit Committee is now chaired by Dhananjay Tapasvi with Suresh Kalra and Amit Kumar Sharma as members. The Nomination and Remuneration Committee comprises Dhananjay Tapasvi (Chairman), Amit Kumar Sharma and Anuradha Suneet Maheshwari. The Stakeholders Relationship Committee is chaired by Anuradha Suneet Maheshwari with Suresh Kalra and Harsh Malhotra. The CSR Committee is chaired by Suresh Kalra with Anuradha Suneet Maheshwari, Sunil Malhotra and Harsh Malhotra.

Other approvals

The Board also approved execution of consultancy agreements with Jogindersingh Gianchand Jaswal, Ketan Ramani and Pritesh Vinodchandra Ramani.

Why it matters

This is a completed change in control. A new owner now holds a majority stake, and the leadership team, board and all four committees have been replaced in one step, with the founding family retaining a smaller 9.95% holding and continuing in a consultancy capacity. The new MD & CEO is described as having over 25 years of leadership experience in the chemicals industry.

More numbers
  • Sale Shares transferred2,38,44,000 equity shares
  • Stake transferred as % of paid-up capital64.26%
  • Sellers' residual holding36,90,000 equity shares
  • Sellers' residual holding %9.95%
  • Term of MD & CEO appointment5 years
  • Term of CFO appointment5 (five) years
  • MD & CEO leadership experienceover 25 (twenty-five) years
  • Whole-time Director experience38 (thirty-eight) years
Source: BSE · 29 Sep 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.